Japan Insulin Drugs Delivery Devices Market to Grow at 2.34% During 2024-2032, Propelled by Rising Prevalence of Diabetes

December 18, 2023 | Healthcare

According to the latest report by IMARC Group, titled “Japan Insulin Drugs Delivery Devices Market Report by Type (Drug, Device), and Region 2024-2032,” the Japan insulin drugs delivery devices market is expected to exhibit a CAGR of 2.34% during the forecast period (2024-2032). Insulin drugs delivery devices are specialized medical tools that enable the controlled and precise delivery of insulin into the body to help regulate glucose levels effectively. They are available in several forms, including pens, pumps, syringes, and jet injectors. They offer ease of use, making it simpler for patients to self-administer insulin injections or infusions, leading to improved adherence to treatment plans. They reduce the hassle and discomfort associated with traditional injection methods, making diabetes management more convenient and less intrusive. They are widely used by pregnant women with gestational diabetes to control their blood sugar levels.

Japan Insulin Drugs Delivery Devices Market Trends:

The rising prevalence of diabetes in Japan represents one of the primary factors driving the demand for improved and more convenient methods of insulin administration. Additionally, the increasing awareness among the masses about the importance of proper insulin delivery and the role of advanced devices in improving overall health outcomes is offering a favorable market outlook in the country. Along with this, the escalating demand for smart insulin pens and insulin pumps equipped with advanced features like Bluetooth connectivity and dose tracking, and integration with smartphone apps, providing patients and healthcare professionals with real-time data and improved control over diabetes management, is facilitating the market growth. Apart from this, continuous technological advancements in insulin drug delivery devices are improving their efficacy and attracting a wider consumer base. Furthermore, governing authorities of the country are actively promoting preventive healthcare measures and diabetes management programs, creating a conducive environment for the growth of the insulin drug delivery devices market. Moreover, rising collaborations and partnerships between pharmaceutical companies, device manufacturers, and healthcare providers in Japan are strengthening the growth of the market.

Market Summary:

  • Based on the type, the market has been segmented into drug [Basal Or Long-Acting Insulins {Lantus (Insulin Glargine), Levemir (Insulin Detemir), Toujeo (Insulin Glargine), Tresiba (Insulin Degludec), and Basaglar (Insulin Glargine)}; Bolus or Fast-Acting Insulins {Novorapid/Novolog (Insulin Aspart), Humalog (Insulin Lispro), Apidra (Insulin Glulisine), Fiasp (Insulin Aspart), and Admelog (Insulin Lispro Sanofi)}; Traditional Human Insulins {Novolin/Mixtard/Actrapid/Insulatard, Humulin, and Insuman}; Combination Insulins Novomix (Biphasic Insulin Aspart), Ryzodeg (Insulin Degludec and Insulin Aspart), Xultophy (Insulin Degludec and Liraglutide), and Soliqua/Suliqua (Insulin Glargine and Lixisenatide)}; and Biosimilar Insulins {Insulin Glargine Biosimilars and Human Insulin Biosimilars} and device [insulin pumps {insulin pump devices, insulin pump reservoirs, and insulin infusion sets}; insulin pens {cartridges in reusable pens and disposable insulin pens}; insulin syringes; and insulin jet injectors}].
  • Region-wise, the market has been segmented into Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.
  • The competitive landscape of the market has also been examined in the report, along with the detailed profiles of the major players operating in the industry.

Report Scope:

Report Features Details
Base Year of the Analysis 2023
 Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Million
Scope of the Report Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment: 
  • Type
  • Region
Types Covered
  • Drug: Basal or Long-Acting Insulins, Bolus or Fast-Acting Insulins, Traditional Human Insulins, Combination Insulins, Biosimilar Insulins
  • Device: Insulin Pumps, Insulin Pens, Insulin Syringes, Insulin Jet Injectors
Regions Covered Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, Shikoku Region
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3699
Five User License: US$ 4699
Corporate License: US$ 5699
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Japan Insulin Drugs Delivery Devices Market to Grow at 2.34% During 2024-2032, Propelled by Rising Prevalence of Diabetes
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More